«

»

Nov 21

Obama & Congress Will Continue Genetic & Biotech Relationship For Financial Gains

By Susanne Posel | Occupy Corporatism

One of Obama’s endeavors is to empower the genetic and biotech industry with the support of embryotic stem cell research. In May, Obama announced that the pharmaceutical corporations

One of Obama’s endeavors is to empower the genetic and biotech industry with the support of embryotic stem cell research. In May, Obama announced that the pharmaceutical corporations and US government were combining forces to find new uses for already established drugs.

The focus of this collaboration will identify new uses for drugs that have already been approved by the Food and Drug Administration (FDA). There may be need for new human trials, putting the general public at a health risk. Engaging in experimental trials to classify specific compounds to be utilized for unintended purposes is highly dangerous.

Genetic engineering has led researchers to discover over 4,500 diseases that need pharmaceutical drugs to combat.

“We need to speed the pace at which we are turning discoveries into better health outcomes,” said Dr. Francis Collins, of the National Institutes of Health (NIH). “NIH looks forward to working with our partners in industry and academia to tackle an urgent need that is beyond the scope of any one organization or sector.”

[More…]

 

Switch to mobile version